Literature DB >> 18411295

Fas/CD95-mediated apoptosis of type II cells is blocked by Toxoplasma gondii primarily via interference with the mitochondrial amplification loop.

Diana Hippe1, Oleksandr Lytovchenko, Ingo Schmitz, Carsten G K Lüder.   

Abstract

The intracellular protozoan Toxoplasma gondii induces persistent infections in various hosts and is an important opportunistic pathogen of humans with immature or deficient immune responses. The ability to survive intracellularly largely depends on the blocking of different proapoptotic signaling cascades of its host cell. Fas/CD95 triggers an apoptotic cascade that is crucial for immunity and the outcome of infectious diseases. We have determined the mechanism by which T. gondii counteracts death receptor-mediated cell death in type II cells that transduce Fas/CD95 ligation via caspase 8-mediated activation of the mitochondrial amplification loop. The results showed that infection with T. gondii significantly reduced Fas/CD95-triggered apoptosis in HeLa cells by inhibiting the activities of initiator caspases 8 and 9 and effector caspase 3/7. Parasitic infection dose dependently diminished cleavage of caspase 8, the BH3-only protein Bid, and the downstream caspases 9 and 3. Importantly, interference with Fas/CD95-triggered caspase 8 and caspase 3/7 activities after parasitic infection was largely dependent on the presence of caspase 9. Within the mitochondrial amplification loop, T. gondii significantly inhibited the Fas/CD95-triggered release of cytochrome c into the host cell cytosol. These results indicate that T. gondii inhibits Fas/CD95-mediated apoptosis in type II cells primarily by decreasing the apoptogenic function of mitochondria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411295      PMCID: PMC2446730          DOI: 10.1128/IAI.01546-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

Authors:  C Scaffidi; I Schmitz; J Zha; S J Korsmeyer; P H Krammer; M E Peter
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

Review 2.  Apoptosis-based therapies and drug targets.

Authors:  U Fischer; K Schulze-Osthoff
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.

Authors:  X M Yin; K Wang; A Gross; Y Zhao; S Zinkel; B Klocke; K A Roth; S J Korsmeyer
Journal:  Nature       Date:  1999-08-26       Impact factor: 49.962

4.  Two CD95 (APO-1/Fas) signaling pathways.

Authors:  C Scaffidi; S Fulda; A Srinivasan; C Friesen; F Li; K J Tomaselli; K M Debatin; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

5.  Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

Authors:  H Li; H Zhu; C J Xu; J Yuan
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

6.  Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

Authors:  X Luo; I Budihardjo; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

7.  Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis.

Authors:  N Yasuhara; S Sahara; S Kamada; Y Eguchi; Y Tsujimoto
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

Review 8.  Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Authors:  E Y Denkers; R T Gazzinelli
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

9.  Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.

Authors:  M S Hu; J D Schwartzman; G R Yeaman; J Collins; R Seguin; I A Khan; L H Kasper
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.

Authors:  S Desagher; A Osen-Sand; A Nichols; R Eskes; S Montessuit; S Lauper; K Maundrell; B Antonsson; J C Martinou
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

View more
  9 in total

1.  P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages.

Authors:  Michael P Lees; Stephen J Fuller; Rima McLeod; Nicola R Boulter; Catherine M Miller; Alana M Zakrzewski; Ernest J Mui; William H Witola; Jessica J Coyne; Aubrey C Hargrave; Sarra E Jamieson; Jenefer M Blackwell; James S Wiley; Nicholas C Smith
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

2.  Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells.

Authors:  Tatsuya Yamada; Tadakimi Tomita; Louis M Weiss; Amos Orlofsky
Journal:  Int J Parasitol       Date:  2011-02-15       Impact factor: 3.981

3.  The complexity of signaling in host-pathogen interactions revealed by the Toxoplasma gondii-dependent modulation of JNK phosphorylation.

Authors:  John C Carmen; R Chase Southard; Anthony P Sinai
Journal:  Exp Cell Res       Date:  2008-10-07       Impact factor: 3.905

4.  Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.

Authors:  Liping Wu; Yilin Pang; Guiqi Qin; Gaina Xi; Shengnan Wu; Xiaoping Wang; Tongsheng Chen
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

5.  Toxoplasma gondii inhibits cytochrome c-induced caspase activation in its host cell by interference with holo-apoptosome assembly.

Authors:  Kristin Graumann; Frieder Schaumburg; Thomas F Reubold; Diana Hippe; Susanne Eschenburg; Carsten G K Lüder
Journal:  Microb Cell       Date:  2015-05-04

Review 6.  Host-Toxoplasma gondii Coadaptation Leads to Fine Tuning of the Immune Response.

Authors:  Thaís Rigueti Brasil; Celio Geraldo Freire-de-Lima; Alexandre Morrot; Andrea Cristina Vetö Arnholdt
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 7.  Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii.

Authors:  Tatiane S Lima; Melissa B Lodoen
Journal:  Front Cell Infect Microbiol       Date:  2019-04-16       Impact factor: 5.293

8.  Toxoplasma gondii Extends the Life Span of Infected Human Neutrophils by Inducing Cytosolic PCNA and Blocking Activation of Apoptotic Caspases.

Authors:  Tatiane S Lima; Sharmila Mallya; Allen Jankeel; Ilhem Messaoudi; Melissa B Lodoen
Journal:  mBio       Date:  2021-01-26       Impact factor: 7.867

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.